Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi
- 31 August 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 81 (4) , 613-615
- https://doi.org/10.1016/0035-9203(87)90430-5
Abstract
Administration of 120 mg/kg/day of ketoconazole for 9 weeks resulted in parasitological cure of at least 78.5% of mice infected with 10 5 blood trypanosomes of Trypanosoma cruzi , strain Y. These results and the fact that ketoconazole is widely used in humans for prolonged therapy of fungal infections without significant side effects strongly suggest that further evaluation of ketoconazole for treatment of Chagas disease is highly desirable.Keywords
This publication has 7 references indexed in Scilit:
- Chagas DiseasePublished by S. Karger AG ,2015
- Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central BrazilTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- EXISTING CHEMOTHERAPY AND ITS LIMITATIONSBritish Medical Bulletin, 1985
- Ketoconazole Inhibition of Intracellular Multiplication of Trypanosoma cruzi and Protection of Mice Against Lethal Infection with the OrganismThe Journal of Infectious Diseases, 1984
- Ketoconazole and other potent antimycotic azoles exhibit pronounced activity againstTrypanosoma cruzi, Plasmodium berghei andEntamoeba histolytica in vivoZeitschrift Fur Parasitenkunde-Parasitology Research, 1984
- Ketoconazole Protects against Infection with Trypanosoma Cruzi in a Murine ModelThe American Journal of Tropical Medicine and Hygiene, 1983
- Present status of chemotheraphy and chemoprophylaxis of human trypanosomiasis in the Western HemispherePharmacology & Therapeutics, 1979